Technical Analysis for AEMD - Aethlon Medical, Inc.

Grade Last Price % Change Price Change
F 0.38 -0.88% 0.00
AEMD closed down 0.88 percent on Friday, November 1, 2024, on 12 percent of normal volume.
Earnings due: Nov 12
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Fell Below 20 DMA Bearish -0.88%
Bollinger Band Squeeze Range Contraction -0.88%
Narrow Range Bar Range Contraction -0.88%
Inside Day Range Contraction -0.88%
50 DMA Resistance Bearish -3.83%
Crossed Above 20 DMA Bullish -3.83%
MACD Bullish Signal Line Cross Bullish -3.83%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 19 hours ago
10 DMA Resistance about 19 hours ago
Down 3% about 19 hours ago
Fell Below Previous Day's Low about 19 hours ago
Down 2 % about 19 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aethlon Medical, Inc. Description

Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The company's Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. It is also developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The company was founded in 1991 and is based in San Diego, California.


Classification

Sector: Technology
Industry: Scientific & Technical Instruments
Keywords: Medicine Cancer Biology Infectious Diseases Treatment Of Cancer Neurological Disorders Coronavirus Hepatitis Viruses Immunodeficiency Urological Disorders Virus Antiviral Drug Exosome Sepsis Therapeutic Device Vesicles

Is AEMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.3499
52 Week Low 0.2375
Average Volume 802,045
200-Day Moving Average 0.91
50-Day Moving Average 0.40
20-Day Moving Average 0.39
10-Day Moving Average 0.39
Average True Range 0.03
RSI (14) 46.52
ADX 17.8
+DI 19.96
-DI 15.39
Chandelier Exit (Long, 3 ATRs) 0.37
Chandelier Exit (Short, 3 ATRs) 0.46
Upper Bollinger Bands 0.42
Lower Bollinger Band 0.36
Percent B (%b) 0.4
BandWidth 13.23
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram 0.0002
Fundamentals Value
Market Cap 958.77 Thousand
Num Shares 2.49 Million
EPS -4.77
Price-to-Earnings (P/E) Ratio -0.08
Price-to-Sales 7.55
Price-to-Book 0.42
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.41
Resistance 3 (R3) 0.41 0.40 0.41
Resistance 2 (R2) 0.40 0.39 0.40 0.41
Resistance 1 (R1) 0.39 0.39 0.39 0.39 0.41
Pivot Point 0.38 0.38 0.38 0.38 0.38
Support 1 (S1) 0.37 0.38 0.37 0.37 0.36
Support 2 (S2) 0.36 0.37 0.36 0.36
Support 3 (S3) 0.35 0.36 0.36
Support 4 (S4) 0.36